Novo Nordisk A/s

Pronova Biopharma Norge As

Novozymes A/s

Pronova Biopharm Norge As

Anette Mullertz

Lene Venke Kofod

Hans Peter Heldt-Hansen

Preben H Olesen

Lene Nonboe Andersen

Markus Sakari Kauppinen

Peter Kamp Hansen

Stephan Christgau

Henrik Dalbo Slashedge

Inge Helmer Knap

Joan Qi Si

Svein Olaf Hustvedt

Gunnar Berge

Niels Munk

Peter Wagner

Tina Sejersgangrd Jacobsen

Christian Lorentz Bagger

Tina Sejersgangard Jakobsen

Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.

Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof

Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self- nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.

Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof

The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of, or. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.

Animal feed additives

The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of Byssochlamus, Chaetomium, Humicola, Malbranchea, Mucor, Myceliophthora, Paecilomyces, Talaromyces, Thermoascus, or Thielavia. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.

An enzyme exhibiting xylanase activity, which enzyme is immunologically reactive with antibody raised against a purified xylanase derived from Aspergillus aculeatus, CBS 101.43. The enzyme may be used for degrading plant cell wall components, e.g., in the preparation of feed, in baking, in the paper and pulp industry, and in connection with separation of wheat into starch and gluten.

Enzymes with xylanase activity from Aspergillus aculeatus

An enzyme exhibiting xylanase activity, which enzyme is immunologically reactive with an antibody raised against a purified xylanase derived from Aspergillus aculeatus, CBS 101.43. The enzyme may be used for degrading plant cell wall components e.g. in the preparation of feed, in baking, in the paper and pulp industry and in connection with separation of wheat into starch and gluten.

Enzyme with xylanase activity

Processing plant material with xylanase

Growing community of inventors

Charlottenlund, Denmark

Anette Mullertz